Category - New Drugs
FDA Approves Fycompa for the Treatment of Partial-Onset Seizures in Pediatric Patients as Young as 4 Years Old
FDA Approves Vizimpro (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer
FDA Approves Emgality (galcanezumab-gnlm) for the Preventive Treatment of Migraine in Adults
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine
FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA)